🔍
投資富邦基因免疫生技ETF(00897)必懂|忽略一個風險報酬少35%|美股基因免溢ETF IDNA|NYSE FactSet全球基因免疫生技指數|Caven投資成長家| - YouTube
Channel: Caven 投資成長家
[0]
Hello Hello everybody
[0]
I predict the stock market is not only free to share true value
[3]
of Caven this movie with me to share
[5]
vaccine stocks lazy bag
[6]
that I believe we must know Fubon Securities Investment Trust recently released a new file
[10]
that this file ETF Fubon ETF is called genetic immunization biotech ETF ETF ah
[14]
known that this file
[15]
covers all investment worldwide on vaccine stocks
[19]
that you must be very aware of
[20]
the recent outbreak of severe
[22]
Taiwan so we bought a vaccine very, very many countries
[25]
like Mozambique Dana, BNT, AZ and our own research and development of high-end
[29]
and a vaccine that its vaccine coverage
[32]
area if it is to control the epidemic, then
[33]
to at least 60% or more
[34]
than 60% coverage of this vaccine is that it want to make two
[37]
so we can see that
[39]
this vaccine must be very very large business opportunities
[41]
that we
[42]
have to share with you today about the vaccine ETF
[45]
ETF shares this file I will share its trends
[47]
and its four investment risk with you
[49]
if it is the first time to to this channel
[50]
to share the channel is mainly invested in US stocks knowledge sets
[52]
you want to know nothing about investment from Taiwan stocks situation, then
[55]
welcome to subscribe track
[56]
I will share useful knowledge to invest here for a week
[58]
believe you will be very Oh that have helped
[60]
us get started without further ado
[71]
that we have to introduce the subject
[73]
of biotechnology is genetic immunization ETF
[75]
that today I will mainly introduce two tranches ETF
[77]
ETF is a file Fubon issued this file is a file in uS stocks and
[79]
ETF ETF (iShare issue) that this is part of
[81]
that outline today outline, then
[83]
issued I will first introduce these two steps ETF
[86]
some of their detailed differences in
[88]
the second part, I would describe these ETF its ESG ratings
[91]
industry category, folding he used to pay the premium as well as the third
[94]
and so on, then I will speak with
[96]
you, then investment in these ETF four main risks you will face
[99]
after that I want you to understand these risks and then do it would be relatively safe
[102]
investment such
[103]
that the first 4 part, I would self-assessment
[106]
that I hope you can deep understanding of today's content
[108]
that their investment will be more helpful Oh
[110]
good that ETF we are introducing today it is in the end what are the characteristics
[112]
of its characteristic major is that it there mRNA technology
[115]
that is now our vaccine technology and it has a
[118]
vaccine for cancer immune therapy
[120]
and some gene-editing technique
[122]
that these three technologies it can be said to be very important
[125]
for our future development of human
[126]
good that I the main is to introduce today two tranches of this ETF
[128]
a file is called genetic immunization biotech ETF Fubon
[131]
his TAIEX code is 00897
[133]
another file is listed on the US stock market
[135]
to its US Stock symbol IDNA is
[137]
that they track the index is exactly the same
[140]
NYSE FactSet global gene are immune Biotech index
[144]
ETF so this two tranches of the same kind of ETF it is basically
[147]
just a file
[148]
in the file is a listing of stocks
[149]
listed on the Taiwan stock market
[150]
in US stocks and a file is another file is a
[152]
company iShare Fubon Taiwan stocks issued by companies
[155]
that into Part of the legislation date if 00897 this file ETF
[158]
it has raised is over
[159]
it is raised
[161]
then the US stock market this file ETF IDNA on September 15, then
[163]
it is June 2019 No. 17 has been listed
[166]
so that if look at the information, then
[167]
IDNA this file ETF
[169]
is information that can be
[171]
part of the cost of internal inquiry, then
[172]
00897 his manager fees, storage fees, listing fees, index licensing fees
[176]
add up to about 1.14%
[178]
IDNA that they track the same index a file
[181]
that its total cost Oh it costs only 0.47%
[184]
00897 is about 2.5 times that part of the holding
[187]
if this kind of IDNA
[189]
two tranches of ETF shares are owned 50 stalls
[192]
that risk premium grade, then 00897 is RR4
[195]
IDNA because it is so that it is
[197]
Wall Street's ETF there is no risk
[199]
that the pay scale level of risk reward
[200]
is that TOP 5 stake we developed the Taiwan
[203]
union, then that part of the core constituents of
[205]
a risk of the pay scale
[206]
are basically about the same probably about 25% of
[209]
that because this two tranches ETF
[210]
the main index is tracked between the same
[212]
index that you may feel that oh wonder why he weights a difference
[215]
that is mainly because of the time it compiled the index
[217]
as well as its re-adjust the time is not the same
[219]
so that there will be a little more or less differences in
[221]
that part of the dividend, then
[222]
00897 is no information to go with
[223]
that IDNA this file ETF
[225]
it is issued four times a year with
[226]
four times recently that
[227]
there is coupon
[228]
that part of the price, then
[230]
the price per share is raised 00897 15 yuan
[233]
NT, then that IDNA is 54.3 dollars per share is
[237]
54.3 per US dollar, then that is probably the 1500 NT
[240]
everybody knows that
[241]
invest primarily in US stocks
[242]
investing with stocks (an an transaction)
[243]
so if you to start with IDNA if
[245]
you just NT $ 1500
[247]
you can start with the IDNA
[248]
00897 that if
[249]
the NT $ 15
[250]
but then it is usually to buy a whole
[252]
or else you basically are difficult to buy good that
[255]
it exists ETF Next we look at
[256]
these two tranches of ETF index they track how it is screening?
[260]
That index filtering logic
[262]
is basically it will be a parent and then index
[264]
it again after screening by screening liquidity
[266]
index constituents are
[268]
then calculated weights
[270]
almost every file ETF
[271]
are relying on this logic then screening
[273]
then we look at this index how does it do
[276]
it's first
[276]
screening of the 43 countries listed common shares then trading
[280]
liquidity of that part of
[281]
the screening, then that
[282]
is free float market capitalization greater than $ 300 million
[284]
that is basically is a small share of that will be more than
[287]
the average three-month turnover
[289]
to more than 200 million dollars
[290]
and that this is part of the liquidity
[292]
that index constituents is how it will be
[294]
screened first by FactSet RBICS classification that
[297]
it would FactSet RBICS
[299]
the company is divided into many different industries
[301]
that these companies you just 50% of the revenue comes from the industry
[305]
that you will be classified in this industry
[307]
so that our side which is to be classified in
[309]
industry-related genetic immunization livelihoods
[311]
that after which it will conduct a keyword research
[314]
is FactSet it will say oh you think
[315]
it is in line with this enterprise which keyword
[318]
then it will be assigned to the keyword you
[319]
like our TSMC
[320]
is in line with some of his grain
[322]
so it's round foundries
[323]
foundry industry is key
[324]
OK
[324]
so that is
[325]
on our side, then he will go by keyword FactSet's
[328]
market capitalization plus you'll get a
[331]
weighted score that then
[332]
this is the index components screening stocks
[334]
and then how to conduct weights
[336]
we just got the score
[338]
from high to low and then
[339]
50 and then discharged into the
[341]
file and then share among the constituent stocks of the heavy weights that
[344]
it will flow freely by market capitalization weighting
[346]
means you the larger the market value of
[347]
your weight more weight
[348]
then what
[349]
your weight limit is 4% single right
[351]
here that someone will ask
[352]
you to say that the equity component weight is 4%
[354]
then why do we have just seen Modena (MRNA) he seems to be 7 %
[356]
Why is this?
[357]
In fact, you can think about
[358]
it, I pretend assets Xiao Ming
[360]
and Xiao Ming assets of 60 million dollars
[362]
that my assets is $ 400,000
[364]
at today's perspective, then
[365]
my weight is how much?
[366]
My weight is 40% of the station's two of us that nickname
[369]
assets is 60% of the assets of the two of us
[371]
but after two months
[372]
Xiaoming his remaining 100,000 600,000 flowers to
[375]
that proportion of our assets how many?
[377]
I became 80% of
[378]
that Xiao Ming became 20%
[380]
So, if you see
[381]
Oh certain weight it was more than the right to its limit of
[383]
this file ETF heavy
[385]
in fact, do not be too surprised
[386]
because the weight will change the
[387]
OK
[388]
Okay, next to this page is the constituent stocks of the listed countries
[390]
have not just talked about 43 countries
[392]
that this is a major 43 countries including Taiwan, the United States, Britain,
[396]
Japan, Hong Kong has
[398]
it then I look at the underlying index in here ETF
[401]
we just talked about not saying it's related to this index ETF
[404]
ETF has 00897 with a file that is called IDNA
[407]
two tranches as this ETF is to track the same index
[410]
that we look at it IDNA its index in the past year
[413]
performance is how it
[414]
IDNA his first buckle fee is 0.47%
[418]
of the portion of the dividend that it if
[419]
it is the last coupon
[421]
of $ 0.55 / share
[423]
so it is with interest
[424]
that there are ways Next we look at this file ETF IDNA Its growth trend (scale)
[428]
So why should I look at this growth trend? (Scale)
[430]
because it can say on behalf of investors in the US stock market which
[433]
he thinks this is what we IDNA tracked by the index
[436]
he has no development potential
[437]
if he is a very good index, then
[439]
basically very, very many institutions
[442]
to Buy this file
[443]
so that it exists ETF ETF that
[444]
one of its cash flow
[445]
will be increasing more and
[446]
more, but we look at this file ETF IDNA it the last year
[450]
it green part is the recent one year, then grow the size of
[452]
the red the word is part of the downsizing (correct)
[455]
then we can see that it's a file size ETF
[458]
is actually not growing very, very quickly
[461]
and then he probably increase about $ 150 million a year
[464]
is actually quite common (stocks ETF point of view)
[465]
that a geographic distribution of stocks, then
[468]
we can see that
[468]
it is mainly distributed in the constituent stocks of that
[471]
portion of uS stocks up about 67% of that is that
[474]
the next part of the stocks of
[476]
the German section contains words Modena good
[478]
company that is part of the BNT (Pfizer vaccine)
[481]
that is relatively Zhidezhuyi
[483]
Germany this file does not contain AZ ETF he is a vaccine
[486]
that Next we look at
[487]
that part of France, Denmark as well as China's proportion of the remaining part of his
[491]
that these other countries probably only about 3% of
[494]
that industry classification of part of the case
[495]
that it exists ETF
[496]
which about 82%
[497]
belong to biotechnology class
[499]
was 12% in the pharmaceutical industry
[501]
that 6% of the part of the case
[502]
is a life sciences Some appliances
[503]
Some of the services and so
[504]
that this
[505]
instrument file ETF
[506]
primarily in US stocks listed company 67% of
[509]
that 28% are other advanced countries
[511]
that 3% of the part of the case is that it exists
[514]
in some emerging markets ETF
[515]
of its major companies market
[517]
value, we can see
[518]
part of the large of words
[519]
is large-cap
[520]
then what
[521]
small part of the word is small caps
[522]
and value of part of the case
[523]
is that Growth part of
[525]
it to our reward
[526]
if dividends word
[527]
is value is the value of shares
[529]
this file share is growth stocks
[531]
is the company to pay our share price growth is mainly
[534]
that we can see
[535]
that it exists mainly belong to his ETF growth stocks part
[538]
probably accounts for about 60% of
[540]
that Next we look at this file
[542]
its ETF MSCI ESG score
[545]
then score it gets BBB
[547]
BBB is
[547]
considered a very, very high, then
[549]
considered quite good
[550]
that IDNA its premium discount discount
[552]
magnitude of what is called the premium?
[553]
This file is the magnitude of the discount or premium to its net worth is saying the ETF share price performance
[558]
difference between them is that if that difference is more and more words
[561]
to say on behalf of the ultimate efficiency of
[562]
this file ETF index
[564]
is not good
[564]
if it is 1 within percent premium discount if
[567]
it exists, said on behalf of ETF
[568]
chase final index of efficiency
[569]
is actually quite good
[571]
that we can look at the IDNA its premium discount
[574]
from are probably
[575]
now been created to 0.75%
[577]
to 0.25% of the so
[578]
between that is quite good
[580]
IDNA his index-tracking efficiency of
[582]
the blue this is that it exists ETF IDNA
[584]
the green part of the case
[585]
is its index
[586]
we can see it index-tracking efficiency
[588]
can be said to be very, very good
[589]
complete Next match that is part of the history we look at
[591]
the history of that part of the remuneration paid if
[594]
Fubon Investment Trust their official website
[595]
that the index can be
[596]
displayed on top of
[597]
me from 2014 until now
[599]
alas it feels that it exists ETF tracking the index
[601]
it return very, very
[603]
high 312%
[604]
of you said that you think oh this file ETF is not the future trend of the trend
[608]
that we look at its most recent year of remuneration
[610]
in fact he recently paid this year
[611]
is probably part of the red SPX is 19.45%
[615]
that the difference between the words of the uS market
[617]
that is part of the 0050 words of the Taiwan
[619]
market, we can see in the last year
[621]
its performance index
[622]
is actually not particularly good
[623]
and it does not in fact better than the overall market remuneration
[625]
it is also quite reasonable
[627]
because, after all, the epidemic from the beginning to now been a year and a half
[630]
of those pharmaceutical companies that want to the rise of
[632]
the rise have been rising over
[633]
now and then we buy it will not buy the stock at the high point of
[636]
this up to you to judge for yourself the
[638]
good that we have just
[638]
OK mainly introduces the
[640]
00897 with two tranches of ETF IDNA this difference
[642]
and this performance index which his performance
[646]
that I do IDNA mainly introduced in the past year
[647]
because the two they tracked file ETF index is the same as
[650]
it was then IDNA final performance index
[652]
is very, very match
[654]
so that I do mainly introduced IDNA
[656]
good then the next I'm going to share
[657]
if we want to invest in this index
[659]
with you this ETF is two steps, then
[660]
four main investment risks we face is that if two tranches ETF
four main investment risks we face
[662]
a risk that the industry boom cycle
[664]
and we know that
[665]
these risk epidemic
[667]
outbreak came after shares
[668]
or some medicine factory shares
[669]
they came to their prosperity
[671]
they came to this stage is the stage that
[673]
it will be the peak of
[674]
the recession it will decline
[676]
when the epidemic in the past when
[677]
they would come to the valley and then when
[679]
it came another wave of epidemic
[681]
prosperity will come to the stage
[682]
like a prosperous stage of these outbreaks are
[684]
part of the shares prior to SARS or some of avian flu
[686]
so do we invest in such stocks epidemic, then
[688]
we need to know it is a scenic loop shares
[690]
epidemic is there are going to have
[692]
to have to go there
[693]
so that each When bits investment
[694]
must understand
[695]
your investment in this industry
[696]
is cyclical stocks oh
[698]
two is that the risk of excessive concentration of industrial stocks and
[701]
then we also know that
[702]
we tracked this index
[703]
it is mainly biotechnology
[704]
as well as pharmaceutical and so on as well as instrument then
[707]
it's part and no other part of the exhibition industry,
[709]
so that if you want to invest in this ETF file
[711]
your asset allocation
[712]
do not say you must do all of the
[714]
assets that it exists only buy ETF
[715]
that is very, very dangerous
[716]
risk that three the part of the case
[718]
is the exchange rate risk
[719]
as long as you invest your foreign exchange risk that the stock will face
[722]
then we take a look at an example
[724]
of NT dollar exchange words
[725]
in 2009
[726]
is NT $ 35 dollar
[728]
probably be 100,000 dollars
[729]
in other words, if we so
[731]
NT $ 3.5 million in 2009, when
[733]
we invested $ 100,000 in stocks
[735]
and then
[736]
to 2021 when the
[737]
NT dollar is 1:28
[739]
this time
[740]
our $ 100,000
[741]
we did not rise nor fall
[743]
we it changed to NT $
[744]
2.8 million, then
[746]
to the rest of me to say that I
[748]
have no money up not
[749]
down, but
[749]
I get paid
[751]
will drop
[751]
it because we invest in such ETF
[753]
we are buying different countries and the company's stock
[756]
so
[757]
these companies will have the most
[759]
national currency into a
[760]
NT $ exchange differences
[761]
that this is what we need to bear the risk
[763]
of exchange rate risk that
[764]
is within four deducted the cost of risk
[765]
suppose we now have 10,000 Taiwan dollars
[767]
then we have to invest in the he was
[769]
the subject of a file and then annualized rate of return is 15% per year to us
[771]
that if we invest in the then 20-year
[773]
cost is deducted from 0% of
[774]
our 10,000 will turn buckle in the
[776]
160,000 fee is 0.5% of our 10,000 will become 150,000
[779]
buckle fee is 1% of the 10 000 137 000 and that this
[782]
will become a
[783]
reward in fact there
[784]
is no difference if the buckle fee if
[786]
we can get 100% pay
[787]
that cost if the buckle is 1%, then
[789]
we 20 years down the
[790]
remuneration only if 84% of
[792]
that 50 years down it
[793]
50 years down the words of
[795]
one percent of the cost of the product within the buckle
[796]
it will eat us for nearly 35% of the remuneration
[799]
that is here Caven want to give you a word
[801]
phrase these 100% of the words that you put 100% of the capital
[803]
then you bear the investment risk
[806]
but the rewards you get
[807]
it because you buckle expenses
[809]
and loss of 35%
[812]
so that you if you must pay attention
[813]
at the time of investment ETF
[815]
of its buckle fee is not something you can accept the
[818]
good that the next time we come to
[820]
the first question of self-cultivation is 00897 which invest in two tranches with IDNA ETF
[823]
ETF will you choose which file it?
[826]
After all, this two tranches of index tracking ETF they
[828]
are exactly the same
[829]
that the first one is 00897
[831]
and the second is a good IDNA
[833]
that the second question which the investment risk is most difficult to accept is that you?
[836]
The first risk concentration risk
[839]
cyclical risk The second risk industrial sector
[841]
third risk exchange rate risk
[843]
within the risk buckle fourth the cost of risk
Most Recent Videos:
You can go back to the homepage right here: Homepage